Characteristics of Induced Ventricular Fibrillation Cycle Length in Symptomatic Brugada Syndrome Patients

被引:3
|
作者
Hiratsuka, Atsushi [2 ]
Shimizu, Akihiko [1 ]
Ueyama, Takeshi [2 ]
Yoshiga, Yasuhiro [2 ]
Doi, Masahiro [2 ]
Ohmiya, Toshihide [2 ]
Yoshida, Masaaki [2 ]
Fukuda, Masakazu [2 ]
Matsuzaki, Masunori [2 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Div Cardiol, Dept Med & Clin Sci, Grad Sch Med, Ube, Yamaguchi 7558505, Japan
关键词
Brugada syndrome; Electrophysiological stimulation; Fast-Fourier transformation analysis; Ventricular fibrillation; FOURIER-TRANSFORM ANALYSIS; ATRIAL-FIBRILLATION; SPECTRAL-ANALYSIS; OUTFLOW TRACT; DEFIBRILLATOR IMPLANTATION; HEART-DISEASE; SUDDEN-DEATH; FREQUENCY; HUMANS; LEADS;
D O I
10.1253/circj.CJ-11-1144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Limited information is available on the ventricular fibrillation (VF) spectrum in Brugada syndrome (BS) patients. We clarified differences in the VF cycle length (CL) using fast-Fourier transformation (FFT) analysis in symptomatic and asymptomatic BS patients. Methods and Results: VF was induced by pacing from the right ventricular (RV) apex and/or RV outflow tract (RVOT) for >8s. A 4096-point FFT analysis of results from 28 male BS patients (51.1 +/- 13.7 years old) was performed. Dominant frequency (DF) from phases 1 (4s) to 6 was obtained at 2-s intervals. The average DF from surface and intracardiac electrograms (ECG: DFECG; ICE: DFICE,, respectively) was compared between symptomatic and asymptomatic patients. Symptomatic patients had a significantly shorter effective refractory period at a CL of 600 ms at the RVOT than asymptomatic patients. DFECG significantly increased with phase (5.64 +/- 0.32 Hz in phase 1 to 6.16 +/- 0.52 Hz in phase 6) and was significantly higher in symptomatic patients than in asymptomatic patients. DFECG had the same characteristics as DFECG. Conclusions: Induced VF in BS patients can be characterized using FFT analysis. Our data support the hypothesis that symptomatic patients have a significantly shorter VF CL than asymptomatic patients. (Circ J 2012; 76: 624-633)
引用
收藏
页码:624 / 633
页数:10
相关论文
共 50 条
  • [41] Differentiation of the high-risk episodes related to ventricular fibrillation in patients with Brugada syndrome
    Take, Y.
    Morita, H.
    Toh, N.
    Nishii, N.
    Nagase, S.
    Nakamura, K.
    Kohno, K.
    Kusano, K.
    Ohe, T.
    Ito, H.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 1112 - 1112
  • [42] Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation
    Ohgo, Takeshi
    Okamura, Hideo
    Noda, Takashi
    Satomi, Kazuhiro
    Suyama, Kazuhiro
    Kurita, Takashi
    Aihara, Naohiko
    Kamakura, Shiro
    Ohe, Tohru
    Shimizu, Wataru
    [J]. HEART RHYTHM, 2007, 4 (06) : 695 - 700
  • [43] Paced-QRS fragmentation as a Novel Predictor for Ventricular Fibrillation in Patients With Brugada Syndrome
    Kataoka, Naoya
    Mizumaki, Koichi
    Tuzino, Yasushi
    Nakatani, Yosuke
    Sakamoto, Tamotsu
    Nishida, Kunihiro
    Inoue, Hiroshi
    [J]. CIRCULATION, 2015, 132
  • [44] Intravenous administration of quinidine gluconate prevents induction of ventricular fibrillation in patients with brugada syndrome
    Ashino, Sonoko
    Watanabe, Ichiro
    Kofune, Masayoshi
    Ohkubo, Kimie
    Okumura, Yasuo
    Kofune, Tatsuya
    Hashimoto, Kenichi
    Shindo, Atsushi
    Sugimura, Hidezou
    Nakai, Toshiko
    SAito, Satoshi
    [J]. CIRCULATION, 2006, 114 (18) : 706 - 706
  • [45] Lymphocytic cell infiltration of myocardium is associated with the episode of ventricular fibrillation in patients with brugada syndrome
    Tanaka, M.
    Nakamura, K.
    Miura, D.
    Nakagawa, K.
    Nishii, N.
    Nagase, S.
    Morita, H.
    Kusano, K.
    Yutani, C.
    Ito, H.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 820 - 820
  • [46] Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome
    Take, Yutaka
    Morita, Hiroshi
    Toh, Norihisa
    Nishii, Nobuhiro
    Nagase, Satoshi
    Nakamura, Kazufumi
    Kusano, Kengo F.
    Ohe, Tohru
    Ito, Hiroshi
    [J]. HEART RHYTHM, 2012, 9 (05) : 752 - 759
  • [47] Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome
    Morita, Hiroshi
    Miyamoto, Masakazu
    Watanabe, Atsuyuki
    Tsukuda, Saori
    Morimoto, Yoshimasa
    Kawada, Satoshi
    Nakagawa, Koji
    Nishii, Nobuhiro
    Ito, Hiroshi
    [J]. HEART RHYTHM, 2018, 15 (10) : 1468 - 1474
  • [48] Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome
    Abud, A
    Bagattin, D
    Goyeneche, R
    Becker, C
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2006, 17 (02) : 210 - 212
  • [49] Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome
    Take, Yutaka
    Morita, Hiroshi
    Wu, Jiashin
    Nagase, Satoshi
    Morita, Shiho
    Toh, Norihisa
    Nishii, Nobuhiro
    Nakamura, Kazufumi
    Kusano, Kengo F.
    Ohe, Tohru
    Ito, Hiroshi
    Zipes, Douglas P.
    [J]. HEART RHYTHM, 2011, 8 (07) : 1014 - 1021
  • [50] Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome
    Morita, H
    Morita, ST
    Nagase, S
    Banba, K
    Nishii, N
    Tani, Y
    Watanabe, A
    Nakamura, K
    Kusano, KF
    Emori, T
    Matsubara, H
    Hina, K
    Kita, T
    Obe, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (09) : 1624 - 1631